Ubamatamab

Tax included
Ubamatamab (REGN4018) is a human bispecific antibody targeted against Mucin 16 (MUC16) and CD3. Ubamatamab demonstrates potent antitumor activity.
MedChemExpress 
HY-P99539

Data sheet

Size
Multiple sizes
Reactivity
CD3
Application
Cancer-programmed cell death
CAS
2305629-50-7